Literature DB >> 22237549

PharmGKB summary: very important pharmacogene information for G6PD.

Ellen M McDonagh1, Caroline F Thorn, José M Bautista, Ilan Youngster, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22237549      PMCID： PMC3382019          DOI： 10.1097/FPC.0b013e32834eb313

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  109 in total

1.  Toxicity of primaquine in Caucasians.

Authors:  C B CLAYMAN; J ARNOLD; R S HOCKWALD; E H YOUNT; J H EDGCOMB; A S ALVING
Journal:  J Am Med Assoc       Date:  1952-08-23

2.  Toxicity of primaquine in Negroes.

Authors:  R S HOCKWALD; J ARNOLD; C B CLAYMAN; A S ALVING
Journal:  J Am Med Assoc       Date:  1952-08-23

3.  Human red cell glucose-6-phosphate dehydrogenase: all active enzyme has sequence predicted by the X chromosome-encoded cDNA.

Authors:  E Beutler; T Gelbart; W Kuhl
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  Structural defects underlying protein dysfunction in human glucose-6-phosphate dehydrogenase A(-) deficiency.

Authors:  F Gómez-Gallego; A Garrido-Pertierra; J M Bautista
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

5.  Subunit interactions of glucose-6-phosphate dehydrogenase from human erythrocytes.

Authors:  P Cohen; M A Rosemeyer
Journal:  Eur J Biochem       Date:  1969-03

6.  Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia.

Authors:  K Iwai; A Hirono; H Matsuoka; F Kawamoto; T Horie; K Lin; I S Tantular; Y P Dachlan; H Notopuro; N I Hidayah; A M Salim; H Fujii; S Miwa; A Ishii
Journal:  Hum Genet       Date:  2001-06       Impact factor: 4.132

7.  [A severe G6PD deficiency revealed during a chemotherapy protocol including rasburicase].

Authors:  P Joly; C Bon; A Francina; M-C Gelineau; P Lacan; H Orfeuvre
Journal:  Ann Biol Clin (Paris)       Date:  2009 Jul-Aug       Impact factor: 0.459

8.  Mutation analysis of glucose-6-phosphate dehydrogenase (G6PD) variants in Costa Rica.

Authors:  E Beutler; W Kuhl; G F Sáenz; W Rodríguez
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

9.  Two structural genes on different chromosomes are required for encoding the major subunit of human red cell glucose-6-phosphate dehydrogenase.

Authors:  H Kanno; I Y Huang; Y W Kan; A Yoshida
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

10.  Certain red cell genetic factors and prevalence of chloroquine-induced pruritus.

Authors:  O G Ademowo; O Sodeinde
Journal:  Afr J Med Med Sci       Date:  2002-12
View more
  10 in total

1.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.

Authors:  M V Relling; E M McDonagh; T Chang; K E Caudle; H L McLeod; C E Haidar; T Klein; L Luzzatto
Journal:  Clin Pharmacol Ther       Date:  2014-05-02       Impact factor: 6.875

2.  No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.

Authors:  Katherine M Robinson; Wenjian Yang; Seth E Karol; Nancy Kornegay; Dennis Jay; Cheng Cheng; John K Choi; Dario Campana; Ching-Hon Pui; Brent Wood; Michael J Borowitz; Julie Gastier-Foster; Eric C Larsen; Naomi Winick; William L Carroll; Mignon L Loh; Elizabeth A Raetz; Stephen P Hunger; Meenakshi Devidas; Elaine R Mardis; Robert S Fulton; Mary V Relling; Sima Jeha
Journal:  Pediatr Blood Cancer       Date:  2019-03-07       Impact factor: 3.167

3.  PharmGKB summary: methylene blue pathway.

Authors:  Ellen M McDonagh; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

Review 4.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Authors:  Ellen M McDonagh; Caroline F Thorn; John T Callaghan; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-09       Impact factor: 2.089

5.  Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.

Authors:  S L Van Driest; Y Shi; E A Bowton; J S Schildcrout; J F Peterson; J Pulley; J C Denny; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2013-11-19       Impact factor: 6.875

Review 6.  Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.

Authors:  Abdoul Karim Ouattara; Pouiré Yameogo; Lassina Traore; Birama Diarra; Maléki Assih; Tegwindé Rébéca Compaore; Dorcas Obiri-Yeboah; Serge Théophile Soubeiga; Florencia Wendkuuni Djigma; Jacques Simpore
Journal:  BMC Med Genet       Date:  2017-11-23       Impact factor: 2.103

7.  G6PD variant distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.

Authors:  Jorge da Rocha; Houcemeddine Othman; Caroline T Tiemessen; Gerrit Botha; Michele Ramsay; Collen Masimirembwa; Clement Adebamowo; Ananyo Choudhury; Jean-Tristan Brandenburg; Mogomotsi Matshaba; Gustave Simo; Francisco-Javier Gamo; Scott Hazelhurst
Journal:  medRxiv       Date:  2020-06-02

8.  Identification, conservation, and expression of tiered pharmacogenes in zebrafish.

Authors:  Catherine Demery-Poulos; Joseph M Chambers
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

9.  G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.

Authors:  Jorge E B da Rocha; Houcemeddine Othman; Caroline T Tiemessen; Gerrit Botha; Michèle Ramsay; Collen Masimirembwa; Clement Adebamowo; Ananyo Choudhury; Jean-Tristan Brandenburg; Mogomotsi Matshaba; Gustave Simo; Francisco-Javier Gamo; Scott Hazelhurst
Journal:  Pharmacogenomics J       Date:  2021-07-23       Impact factor: 3.550

10.  Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.

Authors:  Nicole Laslett; Julianne Hibbs; Max Hallett; Arezoo Ghaneie; Vlasta Zemba-Palko
Journal:  Cureus       Date:  2021-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.